These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3792440)

  • 1. Nafazatrom, an arachidonate metabolism inhibitor, decreases prolactin and GH release.
    Judd AM; Login IS; Ehreth JT; MacLeod RM
    Eur J Pharmacol; 1986 Sep; 128(3):151-6. PubMed ID: 3792440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maitotoxin, a calcium channel activator, increases prolactin release from rat pituitary tumor 7315a cells by a mechanism that may involve leukotriene production.
    Koike K; Judd AM; Login IS; Yasumoto T; MacLeod RM
    Neuroendocrinology; 1986; 43(3):283-90. PubMed ID: 2426623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A possible role of arachidonate metabolism in the mechanism of prolactin release.
    Judd AM; Koike K; MacLeod RM
    Am J Physiol; 1986 Mar; 250(3 Pt 1):E288-95. PubMed ID: 2420203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcitonin decreases thyrotropin-releasing hormone-stimulated prolactin release through a mechanism that involves inhibition of inositol phosphate production.
    Judd AM; Kubota T; Kuan SI; Jarvis WD; Spangelo BL; Macleod RM
    Endocrinology; 1990 Jul; 127(1):191-9. PubMed ID: 2163310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lipoxygenase inhibitor nafazatrom inhibits stimulated prolactin secretion in cultured rat lactotrophs (GH4C1 cells).
    Bjøro T; Larsen V; Englund K; Torjesen PA; Haug E
    Scand J Clin Lab Invest; 1992 Jun; 52(4):297-303. PubMed ID: 1332181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of maitotoxin on 45Ca2+ flux and hormone release in GH3 rat pituitary cells.
    Login IS; Judd AM; Cronin MJ; Koike K; Schettini G; Yasumoto T; MacLeod RM
    Endocrinology; 1985 Feb; 116(2):622-7. PubMed ID: 2578383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrularia thionin increases arachidonate liberation and prolactin and growth hormone release from anterior pituitary cells.
    Judd AM; Vernon LP; MacLeod RM
    Toxicon; 1992 Dec; 30(12):1563-73. PubMed ID: 1488765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arachidonate Metabolism in the Anterior Pituitary: Effect of Arachidonate Inhibitors on Basal and Stimulated Secretion of Prolactin, Growth Hormone and Luteinizing Hormone. II. Hormone Release from Dispersed Pituitary Cells.
    Bihoreau C; Rasolonjanahary R; Gerozissis K; Clauser H; Kordon C
    J Neuroendocrinol; 1990 Aug; 2(4):445-52. PubMed ID: 19215372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A possible role for lipoxygenase and epoxygenase arachidonate metabolites in prolactin release from pituitary cells.
    Judd AM; Spangelo BL; Ehreth JT; MacLeod RM
    Neuroendocrinology; 1988 Oct; 48(4):407-16. PubMed ID: 3145470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that phorbol diester-sensitive protein kinase-C(s) may not be directly involved in secretagogue-stimulated prolactin release and arachidonate liberation.
    Judd AM; Login IS; MacLeod RM
    Endocrinology; 1989 Sep; 125(3):1134-41. PubMed ID: 2503362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine inhibits maitotoxin-stimulated pituitary 45Ca2+ efflux and prolactin release.
    Login IS; Judd AM; MacLeod RM
    Am J Physiol; 1986 Jun; 250(6 Pt 1):E731-5. PubMed ID: 3717333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maitotoxin stimulates hormonal release and calcium flux in rat anterior pituitary cells in vitro.
    Schettini G; Koike K; Login IS; Judd AM; Cronin MJ; Yasumoto T; MacLeod RM
    Am J Physiol; 1984 Oct; 247(4 Pt 1):E520-5. PubMed ID: 6496670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine decreases 7315a tumor cell prolactin release induced by calcium mobilization.
    Judd AM; Koike K; Schettini G; Login IS; Hewlett EL; Yasumoto T; MacLeod RM
    Endocrinology; 1985 Sep; 117(3):1215-21. PubMed ID: 3926467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigations on the role of arachidonic acid metabolism pathways in the antithrombotic activity of nafazatrom and molsidomine.
    Massad L; Plotkine M; Boulu RG
    Thromb Res; 1988 Jun; 50(5):617-25. PubMed ID: 3137682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral nafazatrom in man: effect on inhaled antigen challenge.
    Fuller RW; Maltby N; Richmond R; Dollery CT; Taylor GW; Ritter W; Philipp E
    Br J Clin Pharmacol; 1987 Jun; 23(6):677-81. PubMed ID: 3038156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of nafazatrom-induced inhibition of rat uterus contractions in vitro.
    Cantabrana B; Velasco G; Andrès-Trelles F; Hidalgo A
    Arch Int Pharmacodyn Ther; 1989; 301():285-98. PubMed ID: 2560365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nafazatrom (BAY g 6575), a potent stimulator of prostacyclin release from cardiac and renal vessel wall.
    Klitzke AK
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):220-8. PubMed ID: 6391401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of the arachidonic acid metabolism attenuate the thyroliberin (TRH) stimulated prolactin production without modifying the production of inositolphosphates in GH4C1 pituitary cells.
    Bjøro T; Englund K; Torjesen PA; Haug E
    Scand J Clin Lab Invest; 1993 Apr; 53(2):111-6. PubMed ID: 8469910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of calcium in dopaminergic regulation of TRH- and angiotensin II-stimulated prolactin release.
    Login IS; Judd AM; Kuan SI; MacLeod RM
    Am J Physiol; 1991 Apr; 260(4 Pt 1):E553-60. PubMed ID: 1902061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of arachidonate metabolism in neurotensin-induced prolactin release in vitro.
    Canonico PL; Speciale C; Sortino MA; Scapagnini U
    Am J Physiol; 1985 Sep; 249(3 Pt 1):E257-63. PubMed ID: 3929616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.